PreveCeutical to Develop Sol-Gel N2B Platform for Parkinson's Disease
PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces a program ...